Examples of using Irbesartan and hydrochlorothiazide in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
The active substances are irbesartan and hydrochlorothiazide.
The combination of irbesartan and hydrochlorothiazide has been rarely associated with symptomatic hypotension in hypertensive patients without other risk factors for hypotension.
Coaprovel contains two active substances, irbesartan and hydrochlorothiazide.
Irbesartan and hydrochlorothiazide(at doses up to 300 mg irbesartan/25 mg hydrochlorothiazide)
Karvezide contains two active substances, irbesartan and hydrochlorothiazide.
Efficacy and safety of the combination of irbesartan and hydrochlorothiazide as initial therapy for severe hypertension(defined as SeDBP≥ 110 mmHg) was evaluated in a multicenter, randomized, double-blind, active-controlled,
What Karvezide contains The active substances are irbesartan and hydrochlorothiazide.
The carcinogenic potential of irbesartan and hydrochlorothiazide in combination has not been evaluated in animal studies.
Karvezide is a combination of two active substances, irbesartan and hydrochlorothiazide.
The effect of the combination of irbesartan and hydrochlorothiazide on morbidity and mortality has not been studied.
Coaprovel is a medicine that contains two active substances, irbesartan and hydrochlorothiazide.
that the second SPC obtained by Sanofi for the combination of irbesartan and hydrochlorothiazide is invalid,
Karvezide is a medicine that contains two active substances, irbesartan and hydrochlorothiazide.
Do not take Irbesartan Hydrochlorothiazide BMS if you are allergic(hypersensitive) to irbesartan and hydrochlorothiazide, or any of the other ingredients of Irbesartan Hydrochlorothiazide BMS
Dose titration with the individual components(i. e. irbesartan and hydrochlorothiazide) may be recommended.
namely the combination of irbesartan and hydrochlorothiazide.
No specific information is available on the treatment of overdose with irbesartan and hydrochlorothiazide combinations.
No teratogenic effects were seen in rats given irbesartan and hydrochlorothiazide in combination at doses that produced maternal toxicity.
Some undesirable effects have been reported since the marketing of the combination of irbesartan and hydrochlorothiazide.
Side effects reported in clinical studies for patients treated with the combination of irbesartan and hydrochlorothiazide were.
Taking Irbesartan Hydrochlorothiazide Winthrop with food and drink Irbesartan Hydrochlorothiazide Winthrop can be taken with
Other medicines and Irbesartan Hydrochlorothiazide Zentiva.
Therefore, the combination of lithium and Irbesartan Hydrochlorothiazide BMS is not recommended see section 4.4.